American Oncology Network, Inc. (AONC)

American Oncology Network Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020
Net Income	-5.54	0	0	0
Depreciation & Amortization	16.74	17.08	6.08	3.66
Share-Based Compensation	4.87	0	0.02	0.02
Other Operating Activities	23.74	-26.46	-32.33	33.57
Operating Cash Flow	-18.12	-6.78	-26.34	37.25
Capital Expenditures	-11.58	-5.11	-7.64	-12.22
Acquisitions	0	-0.01	-3.22	-0.93
Change in Investments	-23.96	-8.88	0.16	-1.52
Investing Cash Flow	-35.53	-13.99	-10.69	-14.67
Share Issuance / Repurchase	-0.09	0	0	28.5
Debt Issued / Paid	-1.04	15.55	26.54	-12.24
Other Financing Activities	56.39	-0.21	-	-
Financing Cash Flow	55.27	15.35	26.54	16.26
Net Cash Flow	1.61	-5.43	-10.49	38.83
Free Cash Flow	-29.7	-11.89	-33.98	25.02
Free Cash Flow Margin	-2.32%	-1.03%	-3.60%	3.45%
Free Cash Flow Per Share	-4.44	-1.54	-4.40	3.24

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).